Genoptix, Inc. GXDX is up 18% this morning on heavy volume, as the company is said to be up for sale, and has hired Barclays as its investment bank.
A report from Bloomberg shows that Quest Diagnostics DGX and Sonic Healthcare are potential buyers for the company.
At last check, shares of Genoptix are up $3.30 to $21.27, a gain of 18.3%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in